Drug comparisons
Dobutamine vs Mavacamten
Dobutamine: IV inotrope for acute HF. Mavacamten (Camzyos): oral myosin inhibitor for oHCM. Different indications in cardiac care.
No comparison dimensions are available for this page.
Clinical context
This comparison occurs when differentiating acute inotropic support from targeted therapy for obstructive hypertrophic cardiomyopathy.
Bottom line
Dobutamine and Mavacamten address opposite needs in cardiac contractility and are not alternatives.
All medication comparisons